Transcriptional Expression of Tissue Factor Pathway Inhibitor, Thrombomodulin and von Willebrand Factor in Normal Human Tissues

Summary

Under normal physiologic conditions, tissue factor pathway inhibitor (TFPI) is synthesized primarily by the microvascular endothelium. Using Northern blotting, we studied its transcriptional expression in different organs and compared it with the expression of two other endothelial specific proteins, namely thrombomodulin (TM) and von Willebrand factor (vWF). The order of mRNA expression for each protein was: TFPI–placenta>lung>liver>kidney>heart>skeletal muscle≥pancreas>brain; TM–heart>pancreas>lung>skeletal muscle>kidney≥liver>placenta>brain; and vWF–heart>skeletal muscle>pancreas>lung≥kidney>placenta>brain>liver. Notably, heart expressed TM and vWF mRNA in large amounts and only small amounts of TFPI whereas lung expressed all three mRNAs in significant amounts. Placenta, on the contrary, expressed large amounts of TFPI but only small amounts of TM and vWF mRNAs. Brain by this technique was found to express undetectable amounts of TFPI and TM mRNAs but small amounts of vWF mRNA. The expression of TFPI mRNA in the brain was however detected by RT/PCR and the antigen was localized to the endothelium of microvessels as well as to the astrocytes and oligodendrocytes. Since ultimate expression of proteins is linked to the expression of their mRNAs, our data support a concept that vascular endothelium is made up of phenotypically diverse groups of cells and that endothelial cells of different vascular beds express specific sets of genes that enable them to carry out tissue-specific functions. Importantly, since astrocytes are known to express tissue factor, the TFPI expression by these cells may control coagulation in their microenvironment and their response to injury and inflammation.

• References

• 1 Davie EW, Fujikawa K, Kisiel W. The coagulation cascade. Initiation, maintenance and regulation. Biochemistry 1991; 30: 10363-70.
• 2 Sanders PM, Warn-Cramer BJ, Rao LVM, Maki SI, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 1991; 88: 708-12.
• 3 Broze Jr GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74 (01) 90-3.
• 4 Huang ZF, Higuchi D, Lasky N, Broze Jr GJ. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997; 90: 944-51.
• 5 Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP. Cultured normal hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor – Evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci 1990; 87: 8869-73.
• 6 Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA, Rousseau SM. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 1993; 69: 366-9.
• 7 Yamanobe F, Mochida S, Ohno A, Ishikawa K, Fujiwara K. Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls. Thrombos Res 1997; 85: 493-501.
• 8 Østerud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb Hemost 1995; 73: 873-5.
• 9 Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: Potential therapeutic application. Thromb Haemostas 1997; 78 (01) 471-7.
• 10 Caplice NM, Mueske CS, Kleppe LS, Peterson TE, Broze Jr GJ, Simari RD. Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res 1998; 83: 1264-70.
• 11 Bajaj MS, Steer S, Kuppuswamy MN, Kisiel W, Bajaj SP. Synthesis and expression of tissue factor pathway inhibitor by smooth muscle cells and fibroblasts. Abstract submitted to ISTH Meeting. Washington D. C.: August 1999
• 12 Eddleston M, de la Torre JC, Oldstone MB, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest 1993; 92: 349-58.
• 13 Siebert PD, Larrick JW. PCR Mimics: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 1993; 14: 244-9.
• 14 Lascano EF, Berria MI. PAP labeling enhancement by osmium tetroxidepotassium ferrocyanide treatment. J Histochem Cytochem 1988; 36: 697-9.
• 15 Wang L, Tran ND, Kittaka M, Fisher MJ, Schreiber SS, Zlokovic BV. Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences and regulatory mechanisms. Arterioscler Thromb Vasc Biol 1997; 17: 3139-46.
• 16 Ishii H, Salem HH, Bell CE, Laposata EA, Majerus PW. Thrombomodulin, an endothelial anticoagulant protein is absent from the human brain. Blood 1986; 67: 362-5.
• 17 McCrae KR, Multhaupt H, Samuels P, Cines DB, Wadia M, Novotny WF. Production of the tissue factor pathway inhibitor (TFPI) by human placental trophoblasts. Blood 1992; 80: 1223A.
• 18 Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblasts of human placenta. J Cell Biol 1985; 101: 363-71.
• 19 Bradbury MWB. The structure and function of the blood brain barrier. Fed Proc 1984; 43: 186-90.
• 20 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 86: 1087-97.
• 21 Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromos Res 1990; 59: 421-37.
• 22 Hollister RD, Kisiel W, Hyman BT. Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor in Alzheimer’s disease. Brain Res 1996; 728: 13-9.
• 23 Pindon A, Hantai D, Jandrot-Perrus M, Festoff BW. Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia 1997; 19: 259-68.
• 24 Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 1997; 138: 1117-24.
• 25 Rajotte D, Arp W, Hagedorn M, Korvunen E, Pasqualini R, Ruoslahti E. Molecular heteogeneity of endothelium revealed by in vivo phage display. J Clin Invest 1998; 102: 430-7.
• 26 Levin EG, Santell L, Osborn KG. The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location. J Cell Science 1997; 110: 139-48.
• 27 Graue GE, de Moerloose P, Bulla O, Lou J, Lei Z, Reber G, Mili N, Ricou B, Morel DR, Suter PM. Hemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thromb Haemost 1997; 77: 585-90.